Oxford Biomedica (LON:OXB) Stock Price Up 0.1% – Here’s What Happened

Posted by ABMN Staff on Dec 12th, 2024

Shares of Oxford Biomedica plc (LON:OXB – Get Free Report) rose 0.1% during trading on Wednesday . The stock traded as high as GBX 433.44 ($5.53) and last traded at GBX 430 ($5.49). Approximately 92,890 shares traded hands during mid-day trading, a decline of 54% from the average daily volume of 201,557 shares. The stock had previously closed at GBX 429.50 ($5.48).

Analysts Set New Price Targets

Separately, Deutsche Bank Aktiengesellschaft upped their price objective on shares of Oxford Biomedica from GBX 250 ($3.19) to GBX 380 ($4.85) and gave the company a “hold” rating in a report on Tuesday, September 24th.

Check Out Our Latest Research Report on OXB

Oxford Biomedica Trading Up 0.2 %

The company’s 50 day moving average price is GBX 410.09 and its two-hundred day moving average price is GBX 363.93. The company has a debt-to-equity ratio of 154.88, a current ratio of 2.35 and a quick ratio of 1.67. The stock has a market capitalization of £453.89 million, a PE ratio of -298.61 and a beta of 1.09.

Oxford Biomedica Company Profile

(Get Free Report)

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.